drugset / Trial / NCT05129137
Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)
Phase 1
Completed
32 enrolled
Unither Pharmaceuticals, France
Accutest Research Laboratories (I) Pvt. Ltd. · collab
RandomizedCrossoverOpen-labelHealth-services research
Summary
This study aims to assess the pharmacokinetic profile of a Fixed Dose Combination nefopam hydrochloride (30 mg) / paracetamol (500 mg) and individual components taken alone or concomitantly after oral single dose.
Timeline
- Start
- 2021-11-29
- Primary completion
- 2021-12-27
- Completion
- 2021-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 500 mg | Oral |
| Comparator | Nefopam | Small molecule | 30 mg | Oral |
Indications
No indication recorded.